Perspective Therapeutics (CATX) Accounts Payables (2011 - 2026)
Perspective Therapeutics (CATX) posted Accounts Payables of $26.5 million for Q1 2026, up 29.13% sequentially from $20.5 million in Q4 2025, and up 203.24% YoY from $8.7 million in Q1 2025.
Perspective Therapeutics (CATX) Accounts Payables (2011 - 2026) Analysis & Trends
Perspective Therapeutics has reported Accounts Payables for 16 years, with the latest figure at $26.5 million in Q1 2026.
- Quarterly Accounts Payables rose 203.24% year-over-year to $26.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $26.5 million (up 203.24% YoY) and the FY2025 annual result came in at $20.5 million, up 98.31% from the prior year.
- Accounts Payables climbed to $26.5 million in Q1 2026 per CATX's latest filing, from $20.5 million in the prior quarter.
- Over five years, Accounts Payables peaked at $26.5 million in Q1 2026 and troughed at $769000.0 in Q1 2022.
- A 5-year average of $8.6 million and a median of $6.1 million in 2024 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables surged 464.08% in 2024, then slumped 39.72% in 2025.
- Over 5 years, Accounts Payables stood at $1.5 million in 2022, then soared by 348.35% to $6.9 million in 2023, then surged by 49.7% to $10.3 million in 2024, then jumped by 98.31% to $20.5 million in 2025, then advanced by 29.13% to $26.5 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $26.5 million, $20.5 million, and $13.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 4.79 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | 2.64 Bn |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | 1.23 Bn |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | 210.50 Mn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | 3.23 Bn |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | 2.42 Bn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | 344.10 Mn |
| 10 | Perspective Therapeutics | 386.08 Mn | 386.08 Mn | - | 29.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 29.42 Mn |
| Mar 31, 2026 | 26.49 Mn |
| Dec 31, 2025 | 20.51 Mn |
| Sep 30, 2025 | 13.15 Mn |
| Jun 30, 2025 | 7.05 Mn |
| Mar 31, 2025 | 8.73 Mn |
| Dec 31, 2024 | 10.34 Mn |
| Sep 30, 2024 | 21.81 Mn |
| Jun 30, 2024 | 6.13 Mn |
| Mar 31, 2024 | 6.03 Mn |
| Dec 31, 2023 | 6.91 Mn |
| Sep 30, 2023 | 3.87 Mn |
| Jun 30, 2023 | 4.91 Mn |
| Mar 31, 2023 | 3.91 Mn |
| Dec 31, 2022 | 1.54 Mn |
| Sep 30, 2022 | 2.50 Mn |
| Jun 30, 2022 | 966,000.00 |
| Mar 31, 2022 | 769,000.00 |
| Dec 31, 2021 | 847,000.00 |
| Sep 30, 2021 | 768,000.00 |